Growth Metrics

Intelligent Bio Solutions (INBS) Leases (2022 - 2025)

Intelligent Bio Solutions' quarterly Leases came in at $69520.0 in Q2 2025, down 77.34% year-on-year from $306744.0 in Q2 2024, and down 45.17% quarter-over-quarter from $126798.0 in Q1 2025.

Intelligent Bio Solutions has reported Leases for 4 years, with the latest figure at $69520.0 in Q2 2025.

  • For the quarter ending Q2 2025, Leases fell 77.34% year-over-year to $69520.0; the trailing twelve-month figure through Jun 2025 stood at $69520.0 (down 77.34% YoY), and the FY2025 full-year result was $69520.0, down 77.34% from the prior year.
  • Leases for Q2 2025 stood at $69520.0, down from $126798.0 in the prior quarter.
  • The five-year high for Leases was $546475.0 in Q2 2023, with the low at $69520.0 in Q2 2025.
  • Average Leases over 4 years is $340119.9, with a median of $365512.0 recorded in 2024.
  • Year-over-year, Leases dropped 14.54% in 2023 and plunged 77.34% in 2025.
  • Tracing INBS's Leases over 4 years: stood at $506360.0 in 2022, then fell by 14.54% to $432728.0 in 2023, then sank by 57.79% to $182637.0 in 2024, then plunged by 61.94% to $69520.0 in 2025.
  • The last three Leases figures came in at $69520.0 (Q2 2025), $126798.0 (Q1 2025), and $182637.0 (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Leases (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 547.00 Mn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 99.30 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 73.10 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 396.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 155.20 Mn
10 Intelligent Bio Solutions 13.61 Mn 12.40 Mn - 69,520.00

Historic Data

Download Data 🔒
DateValue
Jun 30, 2025 69,520.00
Mar 31, 2025 126,798.00
Dec 31, 2024 182,637.00
Sep 30, 2024 260,760.00
Jun 30, 2024 306,744.00
Mar 31, 2024 365,512.00
Dec 31, 2023 432,728.00
Sep 30, 2023 471,532.00
Jun 30, 2023 546,475.00
Mar 31, 2023 472,253.00
Dec 31, 2022 506,360.00